These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22357617)

  • 1. Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new perspective for Rett syndrome.
    Squillaro T; Alessio N; Cipollaro M; Melone MA; Hayek G; Renieri A; Giordano A; Galderisi U
    Mol Biol Cell; 2012 Apr; 23(8):1435-45. PubMed ID: 22357617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report: bone marrow mesenchymal stem cells from a Rett syndrome patient are prone to senescence and show a lower degree of apoptosis.
    Squillaro T; Hayek G; Farina E; Cipollaro M; Renieri A; Galderisi U
    J Cell Biochem; 2008 Apr; 103(6):1877-85. PubMed ID: 18059018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence Phenomena and Metabolic Alteration in Mesenchymal Stromal Cells from a Mouse Model of Rett Syndrome.
    Squillaro T; Alessio N; Capasso S; Di Bernardo G; Melone MAB; Peluso G; Galderisi U
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Alpha-Synuclein Gene (SNCA) is a Genomic Target of Methyl-CpG Binding Protein 2 (MeCP2)-Implications for Parkinson's Disease and Rett Syndrome.
    Schmitt I; Evert BO; Sharma A; Khazneh H; Murgatroyd C; Wüllner U
    Mol Neurobiol; 2024 Oct; 61(10):7830-7844. PubMed ID: 38429622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.
    Andoh-Noda T; Akamatsu W; Miyake K; Matsumoto T; Yamaguchi R; Sanosaka T; Okada Y; Kobayashi T; Ohyama M; Nakashima K; Kurosawa H; Kubota T; Okano H
    Mol Brain; 2015 May; 8():31. PubMed ID: 26012557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MeCP2-regulated miRNAs control early human neurogenesis through differential effects on ERK and AKT signaling.
    Mellios N; Feldman DA; Sheridan SD; Ip JPK; Kwok S; Amoah SK; Rosen B; Rodriguez BA; Crawford B; Swaminathan R; Chou S; Li Y; Ziats M; Ernst C; Jaenisch R; Haggarty SJ; Sur M
    Mol Psychiatry; 2018 Apr; 23(4):1051-1065. PubMed ID: 28439102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graded and pan-neural disease phenotypes of Rett Syndrome linked with dosage of functional MeCP2.
    Chen X; Han X; Blanchi B; Guan W; Ge W; Yu YC; Sun YE
    Protein Cell; 2021 Aug; 12(8):639-652. PubMed ID: 32851591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome.
    Martínez de Paz A; Ausió J
    Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural development of methyl-CpG-binding protein 2 null embryonic stem cells: a system for studying Rett syndrome.
    Okabe Y; Kusaga A; Takahashi T; Mitsumasu C; Murai Y; Tanaka E; Higashi H; Matsuishi T; Kosai K
    Brain Res; 2010 Nov; 1360():17-27. PubMed ID: 20816763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative proteomic analysis of Rett iPSC-derived neuronal progenitors.
    Varderidou-Minasian S; Hinz L; Hagemans D; Posthuma D; Altelaar M; Heine VM
    Mol Autism; 2020 May; 11(1):38. PubMed ID: 32460858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
    Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
    BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of MECP2-null Rett Syndrome patient hiPS cells and isogenic controls through X-chromosome inactivation.
    Cheung AY; Horvath LM; Grafodatskaya D; Pasceri P; Weksberg R; Hotta A; Carrel L; Ellis J
    Hum Mol Genet; 2011 Jun; 20(11):2103-15. PubMed ID: 21372149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MeCP2 dependent heterochromatin reorganization during neural differentiation of a novel Mecp2-deficient embryonic stem cell reporter line.
    Bertulat B; De Bonis ML; Della Ragione F; Lehmkuhl A; Milden M; Storm C; Jost KL; Scala S; Hendrich B; D'Esposito M; Cardoso MC
    PLoS One; 2012; 7(10):e47848. PubMed ID: 23112857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuronal non-CG methylation is an essential target for MeCP2 function.
    Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
    Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MECP2 Leads to Activation of P53 and Neuronal Senescence.
    Ohashi M; Korsakova E; Allen D; Lee P; Fu K; Vargas BS; Cinkornpumin J; Salas C; Park JC; Germanguz I; Langerman J; Chronis C; Kuoy E; Tran S; Xiao X; Pellegrini M; Plath K; Lowry WE
    Stem Cell Reports; 2018 May; 10(5):1453-1463. PubMed ID: 29742391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neural stem cells from a mouse model of Rett syndrome are prone to senescence, show reduced capacity to cope with genotoxic stress, and are impaired in the differentiation process.
    Alessio N; Riccitiello F; Squillaro T; Capasso S; Del Gaudio S; Di Bernardo G; Cipollaro M; Melone MAB; Peluso G; Galderisi U
    Exp Mol Med; 2018 Mar; 50(3):1. PubMed ID: 29563495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.